FINWIRES · TerminalLIVE
FINWIRES

Fitch Retains Neutral Outlook on Asia-Pacific Insurance Sector

By

Fitch Ratings has kept a neutral outlook for the Asia-Pacific insurance sector, according to a recent release.

Solid capital buffers, controlled underwriting, and improved asset-liability management mitigate market headwinds, modestly increasing claim inflation, and new regulatory solvency regimes, according to Fitch.

Moderately higher claim costs, along with supply chain disruption from geopolitical tensions, have reduced nonlife underwriting margins in the region, Fitch said.

Increasing health and motor losses pressure profitability in Korea and Indonesia, while home and motor repair costs show stickiness in Australia, the rating agency said.

Rising interest rates, a better reinsurance environment, and prior-period pricing actions offset claim inflation, but late-cycle market and credit risk linger, Fitch said.

Japanese insurers face higher capital requirements through a new economic value-based solvency regulation, while Indonesian counterparts are undergoing the first phase of higher minimum equity requirements, according to Fitch.

Meanwhile, lingering structural issues led to a deteriorating outlook in China and Taiwan, the rating agency said.

Related Articles

Asia

Kim Forest Enterprise Wins NT$110 Million Genome Sequencing Kit Supply Deal

Kim Forest Enterprise (TPE:6645) won a tender to supply whole genome sequencing assay kits to a national hospital in Taiwan under a contract worth NT$110 million, according to a Wednesday Taiwan Exchange filing.Shares slid about 2% in Thursday's late morning trade.The contract runs from June 10, 2026, to Dec. 31, 2028.Kim Forest said the deal is expected to expand its business operations and boost revenue.

TPE:6645
Asia

Beijing Balance Medical Tech to Buy Back Up to 100 Million Yuan Worth of Shares

Beijing Balance Medical Technology (SHA:688198) plans to repurchase shares worth between 50 million yuan and 100 million yuan, according to a Shanghai bourse filing on Thursday.The company will buy back between 359,583 shares and 719,165 shares, which represents 0.26% to 0.52% of the company's total shares, within 12 months after the approval of the board of directors.The maximum repurchase price will be 139.05 yuan per share.The repurchased shares will be used for the company's employee stock ownership plan or equity incentives.The medical device manufacturer's shares rose 1% during the morning trade.

SHA:688198
Asia

MediaTek's Sales Edge Up in April; Shares Drop 3%

MediaTek (TPE:2454) booked consolidated net sales of NT$47.4 billion in May, up 1.5% from NT$46.7 billion in April, according to a Wednesday Taiwan Exchange filing.Shares slid about 3% in Thursday's late morning trade.MediaTek did not provide further details in the filing.

TPE:2454